Why This Matters to You as an NRI
If you participate in Indian financial markets beyond plain vanilla equity trades, this Master Direction directly affects you. The RBI now requires every non individual entity transacting in OTC markets it regulates to carry a Legal Entity Identifier (LEI). Starting January 2027, every OTC derivative transaction must also carry a Unique Transaction Identifier (UTI). Without these identifiers, you or your entity simply cannot execute trades.
This consolidated Master Direction (Notification No. FMRD.MIOD.10/11.01.057/2025-26, dated March 27, 2026) replaces the patchwork of earlier circulars and brings everything under one roof.
What Is an LEI and Who Needs One?
An LEI is a 20 character alphanumeric code that uniquely identifies any entity participating in a financial transaction worldwide. Think of it as a global financial passport for your company, trust, fund, or any non individual entity.
Scope of the LEI Requirement
The LEI mandate covers all OTC transactions by entities other than individuals in these RBI regulated markets:
- Government securities
- Money market instruments
- Foreign exchange instruments
- Derivatives covered under Section 45U of the RBI Act, 1934
Key Rules for NRI Entities
1. You must obtain your LEI from a Local Operating Unit (LOU) accredited by the Global Legal Entity Identifier Foundation (GLEIF). If the LOU is based in India, it must be recognised by the RBI under the Payment and Settlement Systems Act, 2007.
2. Non resident funds without separate legal entity status in their country of incorporation get a practical workaround. For example, if you operate multiple funds registered individually as Foreign Portfolio Investors (FPIs) but they are all managed by a single parent or management company, those funds may use the LEI of the parent or management company.
3. Your LEI must stay current. If your LEI lapses under the global LEI system rules, you become ineligible to transact. Renew it before it expires.
4. No LEI, no trade. The Direction is unambiguous: entities without a valid LEI code shall not be eligible to undertake transactions in RBI regulated financial markets.
5. Market intermediaries must capture your LEI. Entities responsible for executing, reporting, or handling depository functions in these markets must record the LEI of every transacting participant in their systems.
What Is a UTI and When Does It Start?
A UTI is a unique code assigned to each OTC derivative transaction. Globally, regulators use UTIs to get a comprehensive picture of OTC derivatives activity and the risks embedded in it. The UTI framework under this Master Direction comes into effect on January 1, 2027.
Which Transactions Need a UTI?
UTIs apply to all OTC derivative transactions governed by:
- FEMA regulations on foreign exchange derivative contracts (Notification No. FEMA.25/RB-2000 dated May 3, 2000) and the Master Direction on Risk Management and Inter Bank Dealings
- Rupee Interest Rate Derivatives Directions, 2025 (dated December 9, 2025)
- Forward Contracts in Government Securities Directions, 2025 (dated February 21, 2025)
- Credit Derivatives Directions, 2022 (dated February 10, 2022)
- Any other directions the RBI may specify in the future
How Is a UTI Generated?
Each UTI can have a maximum of 52 characters. It starts with the LEI of the entity that generates it, followed by a unique identifier. A UTI stays with a derivative transaction throughout its entire lifecycle.
The RBI has laid out a clear "waterfall" to decide who generates the UTI:
For transactions reportable only in India:
1. The Central Counterparty (CCP), if the CCP is a counterparty 2. The Electronic Trading Platform (ETP), if the trade was executed on one 3. An entity mutually agreed upon by the counterparties 4. CCIL Trade Repository (CCIL TR) as the backstop
For transactions reportable in India and also in a foreign jurisdiction:
1. The CCP, if the CCP is a counterparty 2. The Clearing Member, if a Clearing Member is a counterparty 3. The ETP, if the trade was executed on one 4. Then it depends on reporting timelines: - If the foreign jurisdiction has a sooner reporting deadline, the UTI follows that foreign jurisdiction's requirements - If the foreign jurisdiction does not have a sooner deadline, the counterparties mutually agree on who generates it, with CCIL TR as the final backstop
Cross Border Reporting Grace Period
This is especially relevant for NRIs. When a transaction must be reported in both India and a foreign jurisdiction that has an earlier reporting deadline, you should make reasonable efforts to obtain and report the UTI within that foreign deadline. If you cannot manage it in time, you have up to five Mumbai business days from the transaction date to obtain and submit the UTI to CCIL TR. Any temporary UTI reported in the interim gets treated as an interim UTI and is replaced.
Lifecycle Events
Amendments to a derivative contract after it has been reported to CCIL TR do not require a new UTI. However, a lifecycle event like novation that creates a new transaction will require a fresh UTI.
Investment and Market Impact for NRIs
If You Invest Through an Entity (Company, Trust, Fund, LLP)
Whether you hold Indian government bonds through an FPI structure, trade in interest rate swaps, or use forex derivatives to hedge your rupee exposure, you need a valid LEI. If you have not obtained one yet, do it now because Section A of this Direction took effect immediately on March 27, 2026.
If You Trade Forex as an Individual
Individuals are exempt from the LEI requirement. However, if you route forex transactions through a corporate entity, partnership, or trust, the LEI mandate applies once the transaction hits USD 1 million or more.
Preparing for UTI (January 2027)
If your investment entity deals in OTC derivatives in India, start coordinating with your brokers, clearing members, and custodians now. Ensure your systems and counterparties are ready to generate, receive, and report UTIs by January 1, 2027. The waterfall mechanism means that in most cases, the CCP or ETP will handle UTI generation, but for bilaterally negotiated trades, you and your counterparty need to agree on who generates it.
Broader Market Transparency
These identifiers make Indian financial markets more transparent and aligned with global standards set by CPMI and IOSCO. For NRI investors, this is a positive development. Greater transparency typically means better price discovery, reduced counterparty risk, and improved regulatory oversight, all of which make the Indian OTC market a safer place to deploy capital.
Quick Action Checklist for NRI Entities
| Action | Deadline | |---|---| | Obtain or renew LEI from a GLEIF accredited LOU | Immediately (Section A is already in force) | | Ensure LEI is captured by your broker, custodian, and depository | Immediately | | Verify LEI has not lapsed under global LEI system rules | Ongoing | | Prepare systems and counterparty agreements for UTI reporting | Before January 1, 2027 | | Coordinate with CCIL TR and clearing members on UTI waterfall responsibilities | Before January 1, 2027 |
Legal Basis
This Master Direction draws its authority from Section 45W read with Section 45U of the Reserve Bank of India Act, 1934. It consolidates and supersedes earlier circulars on LEI and UTI implementation (listed in the Annex to the original notification).
Bottom Line
If you are an NRI investing in Indian financial markets through any non individual entity, a valid LEI is no longer optional. It is a hard prerequisite for transacting. And from January 2027, every OTC derivative trade you do will carry a UTI that follows it from execution to maturity. Get your identifiers in order now so your investment activity faces zero disruption.